The role of cardiac catheterization in solving the issue of surgical treatment of symptomatic hypertrophic cardiomyopathy

B.M. Todurov, M.B. Todurov, A.V. Khokhlov, A.A. Kryvosheya, L.R. Stetsiuk, K.S. Boiko, M.V. Stan, V.S. Myronova

References

1. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology. Eur Heart J. 2014;35(39):2733-79. doi:10.1093/eurheartj/ehu284.
2. Bishu K, Coylewright M, Nishimura R. The role of hemodynamic catheterization in the evaluation of hypertrophic obstructive cardiomyopathy: A case series. Catheter Cardiovasc Interv. 2015;86(5):903-12. doi: 10.1002/ccd.25856.
3. Caravita S, Baratto C, Perego GB, Cecchi F, Crotti L, Parati G. Invasive Hemodynamics of Hypertrophic Cardiomyopathy Exercise Versus Isoprotereno. Circulation: Heart Failure. 2020;13:e007000. doi:10.1161/CIRCHEARTFAILURE.120. l007000.
4. El-Sabawi B, Nishimura RA, Guerrero ME, Rihal CS, Eleid MF. Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis. Catheter Cardiovasc Interv. 2020;95(4):830-7. doi:10.1002/ccd.28442.
5. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JCIN. 2011;4:704-9.
6. Jain R, Osranek M, Jan MF, Kalvin LR, Olet S, Allaqaband SQ, Jahangir A, Khandheria BK, Tajik AJ. Marked respiratory-related fluctuations in left ventricular outflow tract gradients in hypertrophic obstructive cardiomyopathy: an observational study. Eur Heart J Cardiovasc Imaging. 2018;19(10):1126-33. doi:10.1093/ehjci/jex215.
7. Kumar S, Van Ness G, Bender A, Yadava M, Minnier J, Ravi S, McGrath L, Song HK, Heitner SB. Standardized goal-directed Valsalva maneuver for assessment of inducible left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. J Amer Soc Echocardiogr. 2018;31(7):791-8. doi:10.1016/j.echo.2018.01.022.
8. Lapenna E, Nisi T, Carino D, Bargagna M, Ruggeri S, Zancanaro E, Del Forno B, Schiavi D, Agricola E, Castiglioni A, Alfieri O, De Bonis M. Hypertrophic cardiomyopathy with moderate septal thickness and mitral regurgitation: long-term surgical results. Eur J Cardiothorac Surg. 2021;60(2):244-51. doi:10.1093/ejcts/ezab097.
9. Lorenzini M, Anastasiou Z, O’Mahony C, Guttman OP, Gimeno JR, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Garcia-Pavia P, Limongelli G, Pavlou M, Elliott PM, Hypertrophic Cardiomyopathy Outcomes investigators. Mortality among referral patients with hypertrophic cardiomyopathy vs the general European Population. JAMA Cardiol. 2020;5(1):73-80. doi: 10.1001/jamacardio.2019.4534.
10. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Diagnosis and evaluation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2022;79(4):372-89. doi: 10.1016/j.jacc.2021.12.002.
11. Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization caboratory of the 21st century. Circulation. 2012;125:2138-50. doi:10.1161/CIRCULATIONAHA.111.060319.
12. Sharkawi MA, Azemi T, Duncan B, Sadiq I. Subaortic Membrane and hypertrophic obstructive cardiomyopathy in the cardiac catheterization lab. ACC Cardiovasc Interv. 2017;10(15):e143-5. doi: 10.1016/j.jcin.2017.05.054.
13. Wang Y, Zhang YM, Dong JG, Cheng LJ, Jiang GH, Zheng JW, Yu WZ. A case report and analysis of hypertrophic obstructive cardiomyopathy causing an illusion of aortic stenosis. Medicine (Baltimore). 2018;97(50):e13711. doi: 10.1097/MD.0000000000013711.